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Abstract 
In Japanese monkey lenses, 3H-labeled fucose and N-acetylneuraminic acid were enzymatically transferred to neolactotetraosylce- 
ramide (nLc4) and III3FucnLc4, respectively, suggesting the presence of a synthetic pathway of IV3NeuAclIl3FucnLc4 via III3FucnLc4 
in monkey lenses. Six rat strains, Wistar, Sprague-Dawley and pigmented strains, contained sialyl-Lewis x gangliosides in non-cataractous 
lenses in a strain-specific manner. Glycosyltransferase say revealed that the transfer of 3H-labeled fucose to nLc4 occurred in all the 
strains, but that the transfer of 3H-labeled N-acetylneuraminic acid to III3FucnLc4 was strain-specific. These results suggested that 
sialyl-Lewis x gangliosides were generally synthesized from neolactotetraosylceramide via Lewis ~ glycolipid (IlI3FucnLc4) in lens 
tissues, differing from other tissues. Combining our results, we propose two synthetic pathways of sialyl-LeX-containing eolacto-series 
gangliosides and A-pathway ganglio-series gangliosides in human senile cataractous lens: one to sialyl-Lewis ~gangliosides from nLc4 
via Lewis × glycolipid, and the other to GDIa from GM3, via GM2 and GMI. 
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1. Introduction 
Lewis (Le) blood-group-related antigens (Le a, Le b, Le c 
and Le J) are carried by both glycosphingolipids (GSLs) 
and glycoproteins of blood cells and body fluids such as 
plasma and saliva [1,2]. Le x, Le y, and the sialylated and/or  
multimeric forms of the antigens are expressed in blood 
cells [3-6] and various tissues such as kidney [7], brain 
[8 - l  l], cochlea [12], and secretions [13]. In addition, some 
Abbreviations: Fuc, fucose; GSL, glycosphingolipid; HP-TLC, high- 
performance thin-layer chromatography; Lex, LewisX; NeuAc, N- 
acetylneuraminic acid; NeuGc, N-glycolylneuraminic acid; Neutral GSLs 
are abbreviated according to the recommendations f the IUPAC-IUB 
Commission on Biochemical Nomenclature (1977), but the suffix OseCer 
is omitted (Eur. J. Biochem. 79, 11-21). Ganglio-series gangliosides are 
abbreviated according to Svennerholm, L. (1964) (J. Lipid Res. 5, 
145-162) 
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Lewis group antigens are expressed as oncofetal antigens 
in embryogenic tissues and transformed cells [14-16]. 
Lens tissues in vertebrates derive from ectoderm and 
are composed of multiple layers of fiber cells and a 
monolayer of epithelial cells [17]. Lens tissues are isolated 
by basement membrane and are known to lack nervous and 
circulatory systems. We first identified a Le x GSL 
(III3FucnLc4) in pooled human cataractous lens tissues 
and described its age-dependent, cataract-related accumula- 
tion [18]. Structural analyses of neutral GSLs and ganglio- 
sides revealed the co-existence of globo-, ganglio- and 
neolacto-series GSLs, and the expression of Le x and sia- 
lyl-Le ~ epitopes on the non-reducing structure of neolac- 
totetraosylceramide (nLc4) [19,20]. However, the synthetic 
pathway of sialyl-Le ~ gangliosides in human lens remains 
unclear because of the absence of the possible precursor, 
sialyl-paragloboside (IV3NeuAcnLc4), in pooled catarac- 
tous lens tissues [20]. Combining our findings on the 
structures of gangliosides and those of neutral GSLs 
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[19,20], we hypothesize the synthetic pathway of human 
lens gangliosides shown in Fig. 1. 
Sialyl-Le x gangliosides were found in non-cataractous 
lenses of rats, pigs and Old World monkeys as well as in 
human cataractous lens. Humans and Old World monkeys 
showed similar GSL compositions, in particular the pres- 
ence of Le X and sialyl-Le x epitopes and the absence of 
a-galactosyl epitope Gal c~ 1-3Gal-R [21]. In this study the 
glycosyltransferase fraction was prepared from freshly iso- 
lated lenses of Japanese monkeys and several rat strains. 
2. Materials and methods 
2.1. Materials 
Monkey non-cataractous lenses from 2-year-old 
Japanese monkeys (Macaca fuscata) were supplied under 
a co-operative program of the Primate Research Institute, 
Kyoto University, Inuyama, Japan. Six strains of 4- and 
8-week-old rats were used in this study. Two closed 
colonies of Sprague-Dawley (SD) rats, SD:Crj and SD:SIc, 
were obtained from Charles River Japan, Tokyo, and 
Sankyo Labo Service, Tokyo, respectively. Two closed 
colonies of Wistar rats, Wistar:Crj and Wistar:Jcl, were 
from Charles River Japan and Japan Clea, Tokyo, respec- 
tively. Two pigmented inbred strains, ACI (ACI/NJcl) 
and Brown Norway (BN/Sea), were purchased from Japan 
Clea. GDP-[1-3H]Fuc (238.7 GBq/mmol, 6.45 Ci/mmol, 
NET-989), CMP-[9-3H]NeuAc (636.4 GBq/mmol, 17.2 
C i /mmol ,  NET-435) and UDP-[1-3H]Gal (392.2 
GBq/mmol, 10.6 Ci/mmol, NET-213) were obtained from 
New England Nuclear, Boston, MA, and unlabeled GDP- 
Fuc, CMP-NeuAc and UDP-Gal were from Sigma, St. 
Louis, MO. Iatrobeads (6RS-8060), neutral GSL and gan- 
glioside standards were obtained from Iatron (Tokyo, 
Japan). a 1-2 and a l -3 /4  fucosidases were purchased 
from Takara Shuzo, Kyoto. 
2.2. Glycosyltransferase assays in lens tissues 
Solubilization of glycosyltransferases wa  carried out at 
0-4°C [22]. Freshly isolated lenses were homogenized in
two volumes of 0.5 M sucrose and 1 mM EDTA in 50 mM 
Hepes buffer (pH 7.2), and centrifuged at 27 000 × g for 
30 min. The resulting pellet was re-homogenized in two 
volumes of the above buffer containing 0.2% Triton X-100 
and centrifuged at 100000 × g for 1 h. The supernatant 
fraction was used for glycosyltransferase say. 
The reaction mixture for fucosyltransferase assay was 
composed of 50 mM cacodylate buffer (pH 6.5), 2% 
Triton CF-54 (Sigma), 30 /xg of neolactotetraosylceramide 
(nLc4, Iatron) or sialyl-paragloboside (IV3NeuAcnLc4, 
Wako Pure Chemicals, Osaka), 10 mM MnC12, 37 kBq (1 
/xCi) of GDP-[3H]Fuc, with or without 100 nmoles of 
unlabeled GDP-Fuc, and 50 /xl of enzyme fraction (about 
800 /zg protein) in a total volume of 200 /~1. In the 
mixture for sialyhransferase assay, GDP-[3H]Fuc, GDP- 
Fuc and MnC12 were replaced with CMP-[3H]NeuAc, 
CMP-NeuAc and MgCI 2, respectively. In some experi- 
ments, III3FucnLc4 and asialoGM2 (Gg3) were prepared 
by Arthrobacter neuraminidase treatment of IV3Neu -
AclII3FucnLc4, which was purified from human catarac- 
tous lenses [20], and GM2 (Wako Pure Chemicals) as 
acceptor GSLs of sialyltransferase. Control experiments 
were performed without acceptor GSLs. 
Enzymatic synthesis of IV3Gal c~nLc4 was examined in 
rat lenses, since rat lens contains IV3Gal c~ nLc4 in place of 
III3FucnLc4 [23]. The reaction mixture for galactosyltrans- 
ferase assay was composed of 50 mM cacodylate buffer 
(pH 7.2), 2% Triton CF-54 (Sigma), 30 ~g of nLc4, 10 
mM MnC12, 37 kBq (1 /zCi) of UDP-[3H]Gal, 50 nmoles 
of unlabeled UDP-Gal, and 50 /xl of enzyme fraction in a 
total volume of 200 /~1. 
After incubation for 16 h at 37°C, reaction mixtures 
were applied to a SEP-PAK C l8 cartridge (Waters, Mil- 
ford, MA) and washed with distilled water to separate 
Ga I czl ~ 4Ga l~1-  4G1c~1-1Cez 
GIC 151 - lee r~Ga I pl - 4G lc 151 - 1Cet 
~?  GlcNAc~l-]Gal[~l-4(]lc~l-leer Gal~l-4GlcNAcpl-)Galpl-4Glc~l-ZCer Gal~I-4GICNA(:~I-3Gal~Z-4GI(;:~I-I~er 
(I.~) > 1 P~e u.z 
GalNAC~1-4Gal~l -4Gla~l  - l eer  Ga l~1-4GlcHAc~I -3Ga I~|  -4G lc~l  - tCer  Ga l  ~1 - 4GlCNAC ~1 - ]Ga I ~1 - 4G lC p t - lC~r  
CI ;LEX- I -  
HeuAc0~2 I,kl ,~1~¢¢¢ 2 PU.¢ G1 
C, alpl-4Glcpl- lCer GalHAcpl-4Galpl-4alcpl-lCer Galpl-3qalNAcJS1-4G4zlpl-4Glcpl-lCer (;lal~I-3GI1NAcpl-4C~Ipl-4Glcpl-lC~" 
] (ova) ] (o~ 3 (c~1) 3 3 (Gin@ 
J > "~ I - ->-  i , 
~u~Q2 N l~=2 ~ACa2 k~U~2 N,luAc a.2 
Fig. 1. Proposed synthetic pathway of neutral GSLs and gangliosides in human lens. Numbered reactions correspond to lanes in Fig. 2a,b. ~, not detected. 
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Fig. 2. Fluorograms of GSLs incorporated from GDP-[3H]Fuc and CMP- 
[3H]NeuAc by monkey lens glycosyltransferases. (a), Transfer to nLc4 
was examined in the presence of 100 nmoles of unlabeled GDP-Fuc and 
CMP-NeuAc, together with GDP-[3H]Fuc (lane 1), CMP-[3H]NeuAc 
(lane 2) and both (lane 3). Control experiments without nLc4 were 
performed with GDP-[3H]Fuc (lane 4) and CMP-[3H]NeuAc (lane 5). 
AsialoGM2 (Gg3) (lane 6) and III3FucnLc4 (lane 7) were also used as 
acceptor GSLs of CMP-[3H]NeuAc. (b), Transfer experiments were 
similarly performed in the absence of unlabeled GDP-Fuc and CMP- 
NeuAc. (c), Transfer of [SH]Fuc to IVSNeuAcnLc4 was examined in the 
presence (lane 2) or absence (lane 1) of unlabeled GDP-Fuc. Labeled 
GSLs in acetone/methanol (9:1) eluate from an Iatrobeads column were 
deve loped  on HP-TLC p lates in the so lvent  o f  
chloroform/methanol/0.25% CaCI, (55:45:10, v /v /v )  and visualized 
by fluorography following 4 (a, b) or 10 weeks (c) of exposure. Standard 
GSLs were detected with orcinol spray. The arrow indicates the position 
of IIISFucnLc4 (LeX). The arrowhead shows an unknown compound. 
sLe x, IV3NeuAcllI3FucnLc4. 
sugar nucleotides from 3H-labeled GSLs. The methanol 
eluate was dried under a nitrogen stream and applied to an 
Iatrobeads column (RS-8040, Iatron, Tokyo). The column 
was washed with chloroform/methanol (98:2, v/v) to 
remove detergents, and the labeled GSLs were eluted with 
acetone/methanol (9:1, v/v) and methanol. The GSLs 
were developed on pre-coated silica gel 60 high-perfor- 
mance thin-layer chromatography (HP-TLC) plates (5641, 
Merck ,  Darmstadt ,  Germany)  us ing  
chloroform/methanol/0.25% CaCI 2 (55:45:10, v /v /v )  
or chloroform/methanol/water (65:25:4, v /v /v )  as the 
solvents and detected by fluorography. 
In some experiments, the transfer product from [SH]Fuc 
to nLc4 was hydrolyzed with a 1-2fucosidase (20 mU) or 
c~l-3/4fucosidase (0.5 mU) at 0.1 M phosphate buffer 
(pH 8.0 and pH 6.5), containing 250 /xg of sodium tan- 
rodeoxycholate overnight at 37°C, respectively. The hydro- 
lyzed GSLs were separated by Folch's partition, and the 
lower organic phase was analyzed by HP-TLC in the 
solvent of chloroform/methanol/water (65:25:4, v /v /v )  
and fluorography. 
2.3. Extraction and partial purification of lens GSLs 
Total lipids were extracted from 10 lenses of 4- and 
8-week-old rats with 20 or more volumes of 
chloroform/methanol (2:1 and 1:2, v/v) as described 
previously [18,21]. Neutral GSLs and gangliosides were 
separated by DEAE-Sephadex A-25 column chromatog- 
raphy (1 X 4 cm, acetate form, Pharmacia LKB Biotech- 
nology Inc., Uppsala, Sweden) by the method of Ledeen et 
al. [24]. Neutral GSLs were partially purified by Iatrobeads 
6RS-8060 column chromatography (1 X 2 cm, Iatron, 
Tokyo) and Folch's partition. Gangliosides were desalted 
through SEP-PAK C~8 cartridge (Waters, Milford, MA). 
Neutral GSLs were developed on pre-coated HP-TLC plates 
(5556, Merck, Darmstadt, Germany) in the solvent system 
of chloroform/methanol/water (65:25:4, v /v /v )  and de- 
tected with orcinol spray. Gangliosides were developed in 
the solvent system of chloroform/methanol/0.25% CaCI2 
(55:45:10, v /v /v )  and detected with resorcinol spray. 
2.4. TLC-immunostaining of neutral GSLs and ganglio- 
sides 
Aliquots of neutral GSLs and gangliosides were devel- 
oped on silica gel TLC plastic sheets (Polygram Sil G, 
Macherey-Nagel, Diiren, Germany) in the same solvents as 
described above. TLC-immunostaining was carried out as 
described previously [ 18,21 ] by using monoclonal nti-Le ~ 
antibody YI2 (IgM, a kind gift of Dr. Reiji Kannagi, Aichi 
Cancer Center, Nagoya). For the detection of sialyl-Le × 
epitopes, the TLC sheets after development were treated 
with Arthrobacter ureafaciens neuraminidase (Nacalai 
Tesque, Kyoto, Japan) prior to TLC-immunostaining. The 
second peroxidase-conjugated antibodies (1:500, affinity- 
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purified, Cappel, West Chester, PA) were overlaid, and 
peroxidase activity was visualized by a Konica immuno- 
staining HRP kit IS-50B (Tokyo). 
3. Results 
3.1. Enzyme activities for  ganglioside synthesis in monkey 
lens 
Our previous tudy suggested that non-cataractous lenses 
of Japanese monkeys had essentially the same ganglioside 
composition as human cataractous lenses, including the 
presence of sialyl-Le ~ gangliosides, GM3, GMI and GDIa 
[21]. In addition, the expression of IV3NeuAcnLc4, 
V I3NeuAcV3 I I I3FucznLc6 ,  GD3,  l l I3FucnLc4 ,  
V3III3Fuc2nLc6 and Gb3 was detected by TLC-immuno- 
staining. Since it is practically impossible to obtain fresh 
human lenses for enzyme preparation, enzyme activities 
for sialyl-Le x ganglioside synthesis were examined using 
glycosyltransferase preparations from Japanese monkey 
lenses. 
Glycosyltransferase assay was performed at different 
sugar nucleotide concentrations by the addition of 100 
nmoles of unlabeled sugar nucleotides (Fig. 2). At high 
concentrations of sugar nucleotides (100.16 nmoles GDP- 
Fuc and 100.058 nmoles CMP-NeuAc) with low specific 
radioactivity (about 369 KBq/mmol ,  9.99 /~Ci/mmol), 
the transfer of [3H]Fuc or [3H]NeuAc to nLc4 was not 
recognized (lanes 1-3, Fig. 2a). Under the control condi- 
tions without nLc4, GSLs in enzyme preparations were 
weakly labeled with the aid of unlabeled GDP-Fuc and 
CMP-NeuAc, producing a small amount of probable 
ii: 
f 
"~ CMH 
-~ CDH 
-q  CTH 
-q  Gb4 
1 2 3 Le x st 
Fig. 4. Fucosidase digestion of the [ 3 H]Fuc transfer product from monkey 
lens glycosyltransferases. The transfer product from [3H]Fuc to nLc4 was 
hydrolyzed with a 1-2fucosidase (lane 2) or a 1-3/4fucosidase (lane 3). 
The hydrolyzed GSLs were analyzed by HP-TLC in the solvent of 
chloroform/methanol/water (65:25:4, v/v/v) and fluorography. Stan- 
dard GSLs were detected with orcinol spray. 1, no enzyme control. Gb4, 
globotetraosylceramide. 
IV3NeuAclII3FucnLc4 (lanes 4 and 5, Fig. 2a). On the 
other hand, [3H]NeuAc was preferably transferred to 
III3FucnLc4, resulting in the label of a band corresponding 
to IV3NeuAclII3FucnLc4 (lane 7, Fig. 2a). 
Under carrier-free conditions (0.16 nmoles GDP-Fuc 
and 0.058 nmoles CMP-NeuAc), [3H]Fuc, but not 
[3H]NeuAc, was transferred to nLc4, and a band corre- 
sponding to III3FucnLc4 was intensely labeled (lanes 1-3, 
LeXsLe x 
-~GM3 
-~GM2 
-~GM1 
~GD3 
-.,~ GDla  
-~GDlb  
-'~ GT lb  
1 2 3 4  1 2 3 4  st 
Fuc NeuAc 
Fig. 3. pH optima of monkey lens glycosyhransferase activities. Transfer of GDP-[3H]Fuc to nLc4 was examined at different pH in the absence of 
unlabeled GDP-Fuc (Fuc). Transfer of CMP-[3H]NeuAc to III3FucnLc4 was examined inthe presence ofunlabeled CMP-NeuAc (NeuAc). Labeled GSLs 
in methanol e uate from the Iatrobeads column were developed on HP-TLC plates in the same solvent as in Fig. 2 and visualized by fluorography. Standard 
GSLs were detected with orcinol spray. The arrow indicates the position of IV3NeuAcllI3FucnLc4. 1, pH 6.0; 2, pH 6,5; 3, pH 7.2; 4, pH 7.8. 
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Fig. 5. TLC-immunostaining of gangliosides from 4- and 8-week-old rat lenses. Ganglioside fractions were prepared from 10 lenses of each rat strain. 
Aliquots (one-twentieth) of lens gangliosides were developed on plastic TLC sheets in the solvent of chloroform/methanol/0.25% CaC12 (55:45:10, 
v /v /v ) .  TLC sheets were immunostained by monoclonal anti-Le x antibody, after incubation with Arthrobacter neuraminidase. Standard gangliosides 
were detected with resorcinol spray. H, gangliosides from human cataractous lens. Left, 4-week-old; right, 8-week-old. 1, Wistar:Jcl; 2, Wistar:Crj; 3, 
SD:SIc; 4, SD:Jcl; 5, ACI/NJcl; 6, BN/Sea. 
Fig. 2b). Control experiments howed the label of 
II13FucnLc4 from GDP-[3H]Fuc, but no label from CMP- 
[3H]NeuAc (lanes 4 and 5, Fig. 2b). Slight fucosylation of 
IV3NeuAcnLc4 was observed at low GDP-Fuc concentra- 
tions, together with the label of an unidentified compound 
(Fig. 2c). Synthesis of GM2 from asialoGM2 was not 
recognized in the presence or absence of unlabeled CMP- 
NeuAc (lane 6, Fig. 2a,b). 
The optimal pH of the fucosyl- and sialyltransferase 
activities responsible for sialyl-Le x ganglioside synthesis 
were found to be around pH 6.5 (Fig. 3). Transfer products 
were not immunologically identified to be Le X GSL or 
-~CMH 
"~ CDH 
.4, CTH 
.~Gb4 
1 23456 1 23456H 
4W 8W 
Fig. 6. TLC-immunostaining of neutral GSLs from 4- and 8-week-old rat lenses. Neutral GSL tractions were prepared from 10 lenses of each rat strain. 
Aliquots (one-twentieth) of lens neutral GSLs were developed on plastic TLC sheets in the solvent of chloroform/methanol/water (65:25:4, v /v /v ) .  TLC 
sheets were immunostained by monoclonal anti-Le x antibody. H, neutral GSLs from human cataractous lens. Left, 4-week-old; right, 8-week-old. Lanes 
1-6 are the same as in Fig. 5. Gb4, globotetraosylceramide. 
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Fig. 7. Gangliosides from 4- and 8-week-old rat lenses. Aliquots (one-tenth) of lens gangliosides were developed on HP-TLC plates in the solvent of 
chloroform/methanol/0.25% CaCI 2 (55:45:10, v /v /v )  and detected with resorcinol spray. Left, 4-week-old; right, 8-week-old. Lanes 1-6 are the same 
as in Fig. 5. 
sialyl-Le x ganglioside because of their presence in enzyme 
preparations (data not shown). The label of [3H]Fuc trans- 
fer product o nLc4 partly decreased after hydrolysis with 
1-3/4 fucosidase, but not c~ 1-2 fucosidase (Fig. 4). 
3.2. Neutral GSLs and gangliosides in rat lenses of several 
strains 
In our previous tudy [21], sialyl-Le x gangliosides were 
found in non-cataractous lenses of aged Wistar rats. How- 
ever, the sialyl-Le X epitopes were not detected in any of 
the rat strains. Some strains expressed several sialyl-Le x- 
positive gangliosides at 4 or 8 weeks of age (Fig. 5). In 
contrast, none of the strains contained Le x epitopes in 
neutral GSLs (Fig. 6). There were no apparent differences 
in the composition of major gangliosides among the six 
strains (Fig. 7). 
Glycosyltransferases were prepared from six strains of 
4-week-old rats to compare the synthetic activities of 
sialyl-Le X gangliosides in lens. Since rat lens expresses 
Ga la  1-3Gal/3 1-4GIcNAc/3 1-3Gal/3 1-4Glc/3 1-1Cer 
(IV 3 Gala nLc4) in place of Le x glycolipid (III 3 FucnLc4) 
[23], the transfer of [3H]Gal to nLc4 was also examined. 
The transfer of [3H]Fuc, [3H]Gal or [3H]NeuAc to nLc4 
was examined in the presence of 50 nmoles of unlabeled 
sugar nucleotides (Fig. 8). [3H]Fuc and [3H]Gal, but not 
[3H]NeuAc, were transferred in all six rat strains. Under 
the control conditions without nLc4, intense transfer of 
-.,t6~13 
--, GM2 
-,,~ GM1 
-4GD3 
- .~GDla  
..,KGDlb 
..,IGT lb  
F S G F S G F S G F S G F S G F $ G .c Le )~ sLe x ST 
1 2 3 4 5 6 
Fig. 8. Fluorogram of GSLs incorporated from GDP-[3H]Fuc, CMP-[3H]NeuAc and UDP-[3H]Gal by rat lens glycosyltransferases. Glycosyltransferase 
fractions were prepared from 10 lenses of 4-week-old rats of several strains. Transfer to nLc4 was examined in the presence of 50 nmoles of unlabeled 
GDP-Fuc, CMP-NeuAc and UDP-Gal, together with GDP-[3HIFuc (F), CMP-[3H]NeuAc (S) and UDP-[3H]Gal (G). Labeled GSLs in methanol eluate 
from the Iatrobeads column were developed on HP-TLC plates as described in Fig. 2, and visualized by fluorography following 4 weeks of exposure. 
Standard GSLs were detected with orcinol spray. The arrow indicates the position of IV3GalanLc4 from rabbit blood cells (RBC). The arrowhead shows 
an unknown compound, which was transferred from UDP-[aH]Gal in control experiments without nLc4. Lanes 1-6 are the same as in Fig. 5. 
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Fig. 9. Fluorogram of GSLs transferred from CMP-[3H]NeuAc to Le ~ 
GSL among six rat strains. Transfer of [3H]NeuAc to III3FucnLc4 was 
examined in the presence of unlabeled CMP-NeuAc. Labeled GSLs in 
methanol e uate from the Iatrobeads column were developed on HP-TLC 
plates as described in Fig. 2 and visualized by fluorography. Standard 
GSLs were detected with orcinol spray. The arrow indicates the position 
of IV3NeuAclII3FucnLc4. Lanes 1-6 are the same as in Fig. 5. 
[3H]Gal was seen to an unknown substrate in the enzyme 
preparations (arrowhead in Fig. 8). On the other hand, 
[3H]NeuAc was transferred to Le x GSL by the addition of 
unlabeled CMP-NeuAc in a strain-specific manner (Fig. 
9). There was a correlation between sialyltransferase activ- 
ity and sialyl-Le x ganglioside xpression in the six strains. 
Anti-Le ~ antibody confirmed that the transfer product 
from unlabeled CMP-NeuAc to nLc4 was Le x GSL 
II I3FucnLc4 (Fig. 10). 
4. Discussion 
Our previous study revealed that human senile catarac- 
tous lens contained sialyl-LeX-containing neolacto-series 
gangliosides, IV3NeuAclI I3FucnLc4 and modified sialyl- 
Le ~ gangliosides, and several ganglio-series gangliosides, 
GM3, GM2, GM1 and GDla  [20]. The absence of sialyl- 
paragloboside (IV3NeuAcnLc4) suggested a unique path- 
way in sialyl-Le x ganglioside synthesis in human lens. 
since IV3NeuAcnLc4 has been reported to be a precursor 
of sialyl-Le x ganglioside and to regulate sialyl-Le x expres- 
sion in transformed cells [22,25-27] and myeloid cells 
[28]. ~1-3 Fucosyltransferase activity from embryonic 
brain also catalyzes the biosynthesis of sialyl-Le ~ ganglio- 
side from IV3NeuGcnLc4 [29]. Some c~2-3 sialyltrans- 
ferases which might be involved in the biosynthesis of the 
sialyl-Le x determinants have been cloned [30-32]. 
Glycosyltransferases from monkey lens preferably 
transferred [3H]Fuc, but not [3H]NeuAc, to nLc4 (Fig. 2). 
At high CMP-NeuAc concentrations (100 nmoles CMP- 
NeuAc plus 0.058 nmole CMP-[3H]NeuAc), Le ~ GSL 
(III3FucnLc4) was a good acceptor GSL of sialyltrans- 
ferase, irrespective of the low specific radioactivity of 
CMP-[3H]NeuAc (369.6 KBq/mmol ,  9.99 /xCi/mmol) .  
However, the transfer of GDP-[3H]Fuc to IV3NeuAcnLc4 
was very low, and the prior transfer of CMP-[3H]NeuAc to 
nLc4 was undetectable. In this study, identification of 
transfer products could not be achieved in monkey lens, 
because glycosyltransferase pr parations contained consid- 
erable amounts of anti-Le "- and anti-sialyl-LeX-positive 
GSLs. The hydrolysis of [3H]Fuc transfer product o nLc4 
with a 1-3/4 fucosidase partly confirmed the Le x struc- 
ture of the product (Fig. 4). 
Although aged Wistar rat lens contained some sialyl- 
Le~-positive gangliosides [21], all of the rat strains did not 
express sialyl-Le × gangliosides (Fig. 5). Le x epitopes, 
however, were not detected even in the cataractous lenses 
of galactosemic rats [33]. In addition, a-galactosyl epitope 
--~ CMH 
- .~ CDH 
"~ CTH 
- '~  Gb4 
123456 
Fig. 10. Immunological identification of the GDP-Fuc transfer product 
among six rat strains. Transfer of Fuc to nLc4 was performed in the 
presence of 100 nmoles of unlabeled GDP-Fuc. The transfer products 
were developed on TLC sheets in the solvent of 
chloroform/methanol/water (65:25:4, v/v/v) and immunostained with 
anti-Le x antibody as in Fig 5. The arrow indicates the position of 
III3FucnLc4. Lanes 1-6 are the same as in Fig. 5. Gb4, globotetraosylce- 
ramide. 
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(Gal c~ I-3Gal-R) was identified in IV 3 Gal ~ nLc4, instead 
of III3FucnLc4 [23]. Glycosyltransferases from six rat 
strains preferably transferred [3H]Fuc to nLc4 (Fig. 7), and 
the product was immunologically identified to be 
III3FucnLc4 (Fig. 9). The transfer of UDP-[3H]Gal to 
nLc4 and an unknown substrate was also detected in all 
the strains (Fig. 7). On the other hand, the transfer of 
[3H]NeuAc to Le x GSL was recognized in Wistar:CrJ, 
SD:Jcl and BN/Sea strains (Fig. 8), which expressed 
several sialyl-Le x gangliosides in non-cataractous lenses 
(Fig. 6). 
Judging from the current findings, it is plausible that the 
prior addition of c~ l-3-fucosyl residue to neolacto type 2 
core chain is critical for the expression of the sialyl-Le X 
epitope in lens gangliosides, rather than the sialylation of 
nLc4. In rat lens, the expression of IV3Galc~nLc4 was 
predominant from common precursor nLc4 [23], and the 
Le x GSL III3FucnLc4 was practically undetectable [21]. 
Since nLc4 and IV3Galc~nLc4 were immunohistochemi- 
cally localized only in mature fibers of Wistar:Crj rat [33], 
it is likely that Le × GSL is readily sialylated by strain- 
specific sialyltransferase in lens fibers. Similarly, the rapid 
synthesis of sialyl-Le x gangliosides from Le x GSL may 
occur in human lenses, because Le x GSL was under the 
detection level in young non-cataractous lenses of humans 
[18]. Further characterization f lens glycosyltransferases 
is currently underway. 
Combining our findings on the structures of ganglio- 
sides and those of neutral GSLs [19,20] and glycosyltrans- 
ferase assay, we propose the synthetic pathway of lens 
GSLs in human lens (Fig. 1). Two distinct pathways 
starting from lactosylceramide exist: one consists of gan- 
glio-series gangliosides from GM3, via GM2 and GM1, to 
GD1 a, and the other of fucosylated neolacto-series sialyl- 
Le~-containing anglioside (IV3NeuAcIII3FucnLc4) and 
CSLEX-l-positive gangliosides, probably modified sialyl- 
Le x gangliosides [20]. A-pathway ganglio-series ganglio- 
sides also may be synthesized from asialoGM2 (Gg3), 
judging from the substantial differences in fatty acid com- 
positions between GM3 and other ganglio-series ganglio- 
sides [20]. However, the sialylation of asialoGM2 was not 
evident (Fig. 2), suggesting that the presence of asialoGM2 
was derived from the degradation of some ganglio-series 
gangliosides. 
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